PRAN Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.2937|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-12.38M|
|Gross Profit Margin (Quarterly)|
|Profit Margin (Quarterly)|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM)||Upgrade|
SA Breaking News02/13 12:45
SA Breaking News02/13 10:29
SA Breaking News02/13 09:15
Reuters - UK Focus09/05 16:49
|10/01/2014||Misc||Prana Biotechnology 2014 Annual Report|
PRAN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Prana Biotechnology is down 39.95% over the last year vs S&P 500 Total Return up 14.77%, Cytokinetics down 22.37%, and Recro Pharma up 108.7%.
Balance Sheet View Statement
Y-Ratings for PRAN
Portfolio Strategies Featuring PRAN
Did Prana Biotechnology make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.pranabio.com
- IR Website: http://pranabio.com/investors/
- HQ Country: Australia
- HQ State/Province: N/A
- Incorporation Country: Australia
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: June 30, 2015
- Est. Current Fiscal Year End: June 30, 2015
- Last Fiscal Quarter End: December 31, 2013
- Last Fiscal Year End: June 30, 2014
- Next Earnings Release: N/A
Prana Biotechnology Ltd is a development stage company in the development of its pharmaceutical products. The Company’s activities include research into Alzheimer’s disease, Huntington’s disease, Parkinson’s disease and other movement disorders.
PRAN Excel Add-In Codes
- Name: =YCI("PRAN","name")
- Description: =YCI("PRAN","description")
- Sector: =YCI("PRAN","sector")
- Industry: =YCI("PRAN","industry")
- Est. Current Fiscal Year End: =YCI("PRAN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.